Subject
Pharmacology (medical),Pharmacology
Reference31 articles.
1. Guidance for Industry Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes [Internet]. 2008[cited 2020 Jan 22]. Available from:https://www.fda.gov/media/71297/download.
2. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes;Zinman;N Engl J Med,2015
3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes;Neal;N Engl J Med,2017
4. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes;Marso;N Engl J Med,2016
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献